PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT02463851

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
L.V.A. Boersma (from the registry)
Registry
  • NCT NCT02463851
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02463851. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2021-04-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation
Acronym
GOLD-FORCE
Intervention (Device)
PVAC GOLD multielectrode catheter
Intervention (Device)
Contact Force single-tip ablation catheter
Lead sponsor
L.V.A. Boersma (class: other)

Record details

Record id
cardio:ct-nct02463851
Content hash
4d894d946d8f2ca00a10143d27d5f68c4cd5d6992e4f8e46a04b2a8ba92118de